Vapotherm Inc(VAPO) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. The company is headquartered in Exeter, New Hampshire and currently employs 276 full-time employees. The firm is focused on the development and commercialization of its high velocity nasal insufflations (Hi-VNI) technology products that are used to treat patients suffering from respiratory distress. Its Hi-VNI technology delivers noninvasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Its Precision Flow systems uses its Hi-VNI technology. The company offers three versions of its Precision Flow systems: Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. Its Precision Flow systems include a capital unit, a single-use disposable and a nasal interface. Its Precision Flow versions are integrated systems that provide precise user control of temperature, air flow and percentage oxygen through a one-button interface.

Current Price

$18.14

RSI

28.528

Beta:

-1.6341

March 31, 2021
-22.2M

69.019 %
73.794 %
24.827 %
12.565 %

$125,733,000
$48,104,000
$42,377,000
$35,597,000
$30,122,000
161.377 %
13.514 %
19.047 %
18.176 %

$-51,502,000
$-51,205,000
$-42,468,000
$-31,005,000
$-23,072,000
-0.580 %
-20.573 %
-36.971 %
-34.384 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.